Tricyclo Ring System Having The Lactone Ring As One Of The Cyclos Patents (Class 549/299)
-
Patent number: 5212078Abstract: Described is a microbiological method for producing the lactone, sclareolide having the structure: ##STR1## and a diol having the chemical structure: ##STR2## using a sclareol derivative having one of the structures: ##STR3## wherein a combination of two or more of the compounds as a substrate and using one of the microorganisms:Cryptococcus albidus, ATCC 20918Bensingtonia ciliata, ATCC 20919Cryptococcus laurentii, ATCC 20920 orCryptococcus albidus, ATCC 20921.Type: GrantFiled: April 25, 1990Date of Patent: May 18, 1993Assignee: International Flavors and Fragrances Inc.Inventors: Mohamad I. Farbood, James A. Morris, Arthur E. Downey
-
Patent number: 5212313Abstract: Compounds of the Formula VII: ##STR1## Wherein: X.sup.1 and X.sup.2 are each independently selected from --H, cyano, alkyl, alkoxy, aryl, carbamoyl, sulphamoyl, COOH and carboxylic acid ester;Z.sup.2 and Z.sup.2 are both --O--;R.sup.1 and R.sup.2 are each independently selected from H, or an optionally substituted alkyl, alkenyl, cycloalkyl, aryl and aralkyl group;R.sup.4, R.sup.5, R.sup.7 and R.sup.8 are each independently --H, halogen or an optionally substituted alkyl, alkenyl or alkoxy group; orR.sup.1 and R.sup.4 or R.sup.2 and R.sup.5 together with N atom and Ring B from a tetrahydroquinolinyl group; and R.sup.6 is selected from H, halogen or an optionally substituted alkyl or alkoxy group and a group NR.sup.1 R.sup.2 in which each of R.sup.1 and R.sup.2 are independently as hereinbefore described and where R.sup.6 is NR.sup.1 R.sup.2, R.sup.6 is the same or different form the NR.sup.1 R.sup.2 group present in Ring B.Type: GrantFiled: October 23, 1991Date of Patent: May 18, 1993Assignee: Imperial Chemical Industries PlcInventors: Ronald W. Kenyon, David F. Newton, Derek Thorp
-
Patent number: 5210230Abstract: A three-step process is described for the preparation of a lignan of the formula ##STR1## This lignan is useful as an intermediate for the preparation of anti-asthmatic pyranylphenyl hydroxyalkylnaphthoic acids.Type: GrantFiled: October 17, 1991Date of Patent: May 11, 1993Assignee: Merck & Co., Inc.Inventor: Joseph F. Payack
-
Patent number: 5189181Abstract: A process for the preparation of a polycyclic dye of the Formula (1): ##STR1## by reacting a substituted acetic acid of the Formula (2): ##STR2## with a compound of the Formula (3): ##STR3## and oxidation of the intermediate leuco compound to dehydrogenate the peripheral heterocyclic rings whereinY is an optionally substituted aromatic or heteroaromatic radical;Ring A is unsubstituted or is substituted by from one to five groups;Z is --NR.sup.1 R.sup.2 ;R.sup.1 and R.sup.2 are each independently H or are independently selected from optionally substituted alkyl, alkenyl, cycloalkyl, aralkyl, aryl and heteroaryl; orR.sup.1 and R.sup.2 together with the nitrogen atom to which they are attached form a heterocyclic ring; orR.sup.1 and R.sup.2 each independently together with the nitrogen to which they are attached and the adjacent carbon atom of Ring B form a heterocyclic ring; andX.sup.1 and X.sup.Type: GrantFiled: January 7, 1992Date of Patent: February 23, 1993Assignee: Imperial Chemical Industries PLCInventors: Nigel Hall, Nigel Hughes, Prakash Patel
-
Patent number: 5183888Abstract: The present invention relates to a process for the preparation of certain polycyclic dyes and in particularly the preparation of a polycyclic dye of Formula I: ##STR1## By reacting a phenyltartronic acid of Formula II: ##STR2## With either a compound of Formula III: ##STR3## or a compound of Formula IV: ##STR4##Type: GrantFiled: November 9, 1990Date of Patent: February 2, 1993Assignee: Imperial Chemical Industries PLCInventors: Ronald W. Kenyon, David F. Newton, Derek Thorp
-
Patent number: 5179092Abstract: A compound having the formula (I): ##STR1## wherein A is --CH.sub.2 --, --O--, or --S--; R.sup.1 is CH.sub.3 or OCH.sub.3 ; R.sup.2 is hydroxy or carboxy which may be optionally esterized or amidated; R.sup.3 is H or a lower alkyl; and n is 0 or an integer of 1 to 6 or a pharmaceutically acceptable salt thereof.Type: GrantFiled: July 30, 1991Date of Patent: January 12, 1993Assignee: Suntory LimitedInventors: Toshio Tatsuoka, Kenji Suzuki, Fumio Satoh, Seiji Miyano, Kunihiro Sumoto
-
Patent number: 5106995Abstract: A method for converting 1,4 and 1,5 aliphatic saturated diols to lactones is disclosed wherein the diol is reacted with a chemical oxidizing agent and a ruthenium containing catalyst at temperatures substantially less than 200.degree. C. The reaction proceeds quickly and produces high yields of the desired product.Type: GrantFiled: May 5, 1989Date of Patent: April 21, 1992Assignee: ISP Investments Inc.Inventor: Jeffrey S. Plotkin
-
Patent number: 5093501Abstract: Castanospermine is prepared by starting from 5-(t-BOC)amino-5-deoxy-1,2-O-isopropylidene-.alpha.-D-glucuronolactone. Two additional carbons are added to the starting material using ethyl acetate and a strong base and the resulting cyclic hemiketal is subjected to a series of reductions, with intervening removal of protecting groups, to give the castanospermine. A substituted hydroxypyrrolidinone and a substituted hydroxypyrrolidine serve as intermediates in the process.Type: GrantFiled: June 10, 1991Date of Patent: March 3, 1992Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Peter B. Anzeveno, Paul T. Angell, Laura J. Creemer
-
Patent number: 5084580Abstract: Compounds of the Formula VII: ##STR1## wherein; X.sup.1 and X.sup.2 are each independently selected from H, cyano, alkyl, alkoxy, aryl, carbamoyl, sulphamoyl, COOH and carboxylic acid ester;Z.sup.1 and Z.sup.2 are both --O--;R.sup.1 and R.sup.2 are each independently selected from H, or an optionally substituted alkyl, alkenyl, cycloalkyl, aryl and aralkyl group; orR.sup.1 and R.sup.2 together with the N atom to which they are attached, form a heterocycle;R.sup.4, R.sup.5, R.sup.7 and R.sup.8 are each independently selected from E, halogen, or an optionally substituted alkyl, alkenyl and alkoxy group orR.sup.1 and R.sup.4 or R.sup.2 and R.sup.5 together with the N atom and the two carbon atoms in Ring B to which they are attached form a heterocycle fused to Ring B; orR.sup.1 and R.sup.7 or R.sup.2 and R.sup.8 together with the N atom and the two carbon atoms in Ring A to which they are attached form a heterocycle fused to Ring A; orR.sup.Type: GrantFiled: September 21, 1989Date of Patent: January 28, 1992Assignee: Imperial Chemical Industries PLCInventors: Ronald W. Kenyon, David F. Newton, Derek Thorp
-
Patent number: 5077416Abstract: A heterocyclic compound of the formula, ##STR1## wherein A and B are each hydrogen, alkyl or alkoxy, Y is hydrogen, alkyl, alkoxy or --O--R.sup.2 --X--R.sup.1, or Y and B are taken together with each other to form methylenedioxy, R.sup.1 is alkyl, phenyl or alkenyl, R.sup.2 is unsubstituted or substituted alkylene, and X is --O--, --S--, --SO--, --SO.sub.2 -- or ##STR2## in which R.sup.3 is hydrogen or alkyl, with the proviso that R.sup.1 is C.sub.3 or C.sub.4 alkyl or alkenyl, or C.sub.1 -C.sub.4 alkyl when R.sup.2 is unsubstituted ethylene or propylene, respectively, X is --O-- or --S--, and Y and B don't form methylenedioxy, which is useful for dyeing or printing hydrophobic fiber materials with superior dyeability to give a dyed or printed product of a red color excellent in fastness properties, particularly those such as washing fastness.Type: GrantFiled: September 15, 1989Date of Patent: December 31, 1991Assignee: Sumitomo Chemical Co. Ltd.Inventors: Yasuyoshi Ueda, Jun Yamamoto, Takashi Omura, Hideo Hattori, Shinei Ikeou, Yosuke Yamamoto
-
Patent number: 5066807Abstract: Castanospermine is prepared by starting from 5-(t-BOC)amino-5-deoxy-1,2-O-isopropylidene-.alpha.-D-glucuronolactone. Two additional carbons are added to the starting material using ethyl acetate and a strong base and the resulting cyclic hemiketal is subjected to a series of reductions, with intervening removal of protecting groups, to give the castanospermine. A substituted hydroxypyrrolidinone and a substituted hydroxypyrrolidine serve as intermediates in the process.Type: GrantFiled: March 12, 1990Date of Patent: November 19, 1991Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Peter B. Anzeveno, Paul T. Angell, Laura J. Creemer
-
Patent number: 5066669Abstract: A novel biphenyl derivative of the formula: ##STR1## wherein Ring A is a substituted or unsubstituted sulfur-containing or oxygen-containing heteromonocyclic ring; Ring B is a ring of the formula: ##STR2## each of R.sup.1 and R.sup.3 is hydrogen atom, a halogen atom or a lower alkoxy group, or R.sup.1 is hydrogen atom, and R.sup.2 and R.sub.3 are combined together to form a lower alkylenedioxy group; R.sup.4 is a lower alkyl group which may have a substituent selected from a lower alkoxy group and a lower alkoxycarbonyl group; Y is methylene group or carbonyl group, and a pharmaceutically acceptable salt thereof are disclosed. Said derivative and a pharmaceutically acceptable salt thereof are useful as a therapeutic or prophylactic agent for hepatic diseases.Type: GrantFiled: March 7, 1990Date of Patent: November 19, 1991Assignee: Tanabe Seiyaku Co., Ltd.Inventors: Tameo Iwasaki, Masaki Sugiura, Yuzo Matsuoka, Mamoru Matsumoto, Kazuyuki Kitamura
-
Patent number: 5026726Abstract: A compound of the chemical formula ##STR1## wherein n is 1 or 2, X is NH and O, and R.sub.1 and R.sub.2 are H, (C.sub.1 -C.sub.12) alkyl, (C.sub.2 -C.sub.12)alkenyl, (C.sub.2 -C.sub.12)alkynyl, (C.sub.2 -C.sub.12)acyl, (C.sub.6 -C.sub.12)aryl or (C.sub.7 -C.sub.21)alkylaryl, salts thereof and a composition thereof. In vivo and in vitro methods of inhibiting the growth of a virus relying on the effect of the above compound. In vitro and in vivo methods of inhibiting the growth of the HIV-1 virus comprising administering a compound of the formula ##STR2## wherein n is 1 or 2, X is NH or O, and R.sub.1 and R.sub.2 are independently of one another H, (C.sub.1 -C.sub.12)alkyl, (C.sub.2 -C.sub.12)alkenyl, (C.sub.2 -C.sub.12)alkynyl, (C.sub.2 -C.sub.12)acyl, (C.sub.6 -C.sub.12)aryl or (C.sub.7 -C.sub.21)alkylaryl, R.sup.3 is C.dbd.N or COR.sup.5, wherein R.sup.5 is selected from the group consisting of H, (C.sub.1 -C.sub.12) alkyl, alenyl or alkynyl, HO, NH.sub.2 and (C.sub.2 -C.sub.12) alkoxy, and R.sup.Type: GrantFiled: December 11, 1989Date of Patent: June 25, 1991Assignee: The University of New MexicoInventors: David L. Jagt, Robert E. Royer
-
Patent number: 5011948Abstract: There is provided a novel and efficient stereoselective total synthesis of epipodophyllotoxin and related epipodophyllotoxin compounds of the general formula ##STR1## wherein R.sup.1 and R.sup.2 each are independently hydrogen or (lower)alkoxy, or R.sup.1 and R.sup.2, taken together, is methylenedioxy; R.sup.4 and R.sup.6 each are independently hydrogen or (lower)alkoxy; and R.sup.5 is hydrogen or a phenol-protecting group; or an acid addition salt thereof. The present invention also provides novel intermediates and processes for the preparation of said intermediates, which are then converted into known antineoplastic agents.Type: GrantFiled: July 14, 1989Date of Patent: April 30, 1991Assignee: Bristol-Myers CompanyInventors: Dolatrai M. Vyas, Paul M. Skonezny
-
Patent number: 5003087Abstract: A novel process for preparing a naphthalene derivative of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are a lower alkoxycarbonyl group or both may combine to form a group of the formula ##STR2## one of R.sup.3 and R.sup.4 is hydrogen atom or a lower alkoxy group and the other is a lower alkoxy group; ring A is a substituted or unsubstituted benzene ring, which is useful as a hypolipidemic agent, and a novel intermediate of the formula: ##STR3## wherein R1, R2, R3, R4 and ring A are the same as defined above.Type: GrantFiled: January 5, 1990Date of Patent: March 26, 1991Assignee: Tanabe Seiyaku Co., Ltd.Inventors: Tameo Iwasaki, Hiroshi Ohmizu, Masami Takahashi
-
Patent number: 4994584Abstract: The present invention provides new compound, 10-substituted-5,9-dioxatricyclo[6.4.0.0.sup.2,6 ]dodecane-4-one, which is very useful as an intermediate for prostaglandin synthesis.Type: GrantFiled: January 19, 1990Date of Patent: February 19, 1991Assignee: Kabushiki Kaisha Ueno Seiyaku Oyo KenkyujoInventors: Ryuzo Ueno, Ryuji Ueno, Tomio Oda
-
Patent number: 4918202Abstract: The present invention provides new compound, 10-substituted-5,9-dioxatricyclo[6.4.0.0.sup.2,6 ]dodecane-4-one, which is very useful as an intermediate for prostaglandin synthesis.Type: GrantFiled: July 28, 1989Date of Patent: April 17, 1990Assignee: Kabushiki Kaisha Ueno Seiyaku Oyo KenkyujoInventors: Ryuzo Ueno, Ryuji Ueno, Tomio Oda
-
Patent number: 4916240Abstract: Compounds of the general formula: ##STR1## wherein Z.sup.1 and Z.sup.2 are each independently --O--, --S-- or --NR.sup.5 -- in which R.sup.5 is hydrogen, an optionally substituted hydrocarbon group or an acyl group;X.sup.1 and X.sup.2 are selected from hydrogen, halogen, cyano, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, aryl, carbamoyl, sulphamoyl, carboxy or carboxylic acid ester;R.sup.1 is an optionally substituted aryl radical;A is an optionally substituted alkyl radical or a radical of the formula:R.sup.2 --(CH.dbd.CH).sub.n --in whichR.sup.2 is an optionally substituted aryl or heterocyclic radical, andn has a value of 1 or 2.The compounds are useful as dyes for synthetic textile materials.Type: GrantFiled: May 26, 1988Date of Patent: April 10, 1990Assignee: Imperial Chemical Industries PLCInventor: Ronald W. Kenyon
-
Patent number: 4904693Abstract: This invention relates to indenofuran derivatives of the formula: ##STR1## wherein R stands for H or for a ##STR2## group optionally substituted on the phenyl ring by Alk, OH or OAlk, Alk being a lower straight or branched alkyl group up to C.sub.5, to the preparation of these compounds and to therapeutic compositions containing the same in the field of anaphylaxis.Type: GrantFiled: November 4, 1988Date of Patent: February 27, 1990Assignee: Societe de Conseils Recherches et d'Applications ScientifiquesInventors: Pierre Braquet, Andre Esanu
-
Patent number: 4900844Abstract: A process for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains comprising reacting an oxophthalizinyl acetic acid ester with an aniline derivative is disclosed. Also disclosed are processes for the preparation of such oxopthalizinyl esters.Type: GrantFiled: May 19, 1989Date of Patent: February 13, 1990Assignee: Pfizer Inc.Inventors: Banavara L. Mylari, William J. Zembrowski
-
Patent number: 4897418Abstract: Naphthalene derivative of the formula: ##STR1## wherein R.sup.1 is hydrogen atom or a lower alkoxycarbonyl and R.sup.2 is a lower alkoxycarbonyl, or R.sup.1 and R.sup.2 are combined together to form a group of the formula: ##STR2## each of R.sup.3 and R.sup.4 is a lower alkoxy, or one of R.sup.3 and R.sup.4 is hydrogen atom and the other is a lower alkoxy, andRing A is a substituted or unsubstituted benzene ring, and a pharmaceutically acceptable salt thereof are disclosed. Said naphthalene derivative (I) and its salt have excellent hypolipidemic activity and are useful for treatment or prophylaxis of hyperlipidemia and/or arteriosclerosis.Type: GrantFiled: January 11, 1988Date of Patent: January 30, 1990Assignee: Tanabe Seiyaku Co., Ltd.Inventors: Tameo Iwasaki, Kohki Takashima
-
Patent number: 4827845Abstract: Hydroxy aryl carboxylic acids are formed by reacting a hydroxy aryl compound, such as phenol, with a ketone, such as acetone and carbon monoxide in the presence of a strong acid. The preferred embodiment is the one step formation of 2-methyl-2-(p-hydroxyphenyl) propionic acid from phenol, acetone and carbon monoxide in the presence of hydrofluoric acid. When this reaction is conducted in the presence of methanol the corresponding methyl ester is formed.Type: GrantFiled: September 23, 1987Date of Patent: May 9, 1989Assignee: Ashland Oil, Inc.Inventors: Dace Grote, William L. Embry, Kenneth W. Barnett
-
Patent number: 4771072Abstract: Naphthalene derivative of the formula: ##STR1## wherein R.sup.1 is hydrogen atom or a lower alkoxycarbonyl andR.sup.2 is a lower alkoxycarbonyl, or R.sup.1 and R.sup.2 are combined together to form a group of the formula: ##STR2## each of R.sup.3 and R.sup.4 is a lower alkoxy, or one of R.sup.3 and R.sup.4 is hydrogen atom and the other is a lower alkoxy, andRing A is a substituted or unsubstituted benzene ring, and a pharmaceutically acceptable salt thereof are disclosed. Said naphthalene derivative (I) and its salt have excellent hypolipidemic activity and are useful for treatment or prophylaxis of hyperlipidemia and/or arteriosclerosis.Type: GrantFiled: December 30, 1985Date of Patent: September 13, 1988Assignee: Tanabe Seiyaku Co., Ltd.Inventors: Tameo Iwasaki, Kohki Takashima
-
Patent number: 4758433Abstract: A preparation for pharmaceutical use, especially in the treatment of migraine, arthritis and bronchial complaints contains a sesquiterpene lactone and is recovered from the plant Tanacetum parthenium by extraction using a pharmaceutically acceptable oil.Type: GrantFiled: June 26, 1985Date of Patent: July 19, 1988Assignee: R. P. Scherer Corp.Inventors: Edward S. Johnson, Peter J. Hylands, Deborah M. Hylands nee Jessup
-
Patent number: 4728740Abstract: There is provided a novel and efficient stereoselective total synthesis of epipodophyllotoxin and related epipodophyllotoxin compounds of the general formula ##STR1## wherein R.sup.1 and R.sup.2 each are independently hydrogen or (lower)alkoxy, or R.sup.1 and R.sup.2, taken together, is methylenedioxy; R.sup.4 and R.sup.6 each are independently hydrogen or (lower)alkoxy; and R.sup.5 is hydrogen or a phenol-protecting group; or an acid addition salt thereof. The present invention also provides novel intermediates and processes for the preparation of said intermediates, which are then converted into known antineoplastic agents.Type: GrantFiled: September 15, 1986Date of Patent: March 1, 1988Assignee: Bristol-Myers CompanyInventors: Dolatrai M. Vyas, Paul M. Skonezny
-
Patent number: 4683325Abstract: Compounds having the formula: ##STR1## are antagonists of leukotrienes of C.sub.4, D.sub.4 and E.sub.4, the slow reacting substance of anaphylaxis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.Type: GrantFiled: October 17, 1984Date of Patent: July 28, 1987Assignee: Merck Frosst Canada, Inc.Inventors: Richard Frenette, Joshua Rokach, Masatoshi Kakushima, Robert N. Young
-
Patent number: 4680417Abstract: A compound of the formula: ##STR1## wherein, Z.sup.1 and Z.sup.2 are each independently - O -, - S - or - NR.sup.5 - in which R.sup.5 is H or an optionally-substituted hydrocarbon group or an acyl group;X.sup.1 and X.sup.2 are selected from H, halogen, cyano, C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, aryl, carbamoyl, sulphamoyl, carboxylic acid or carboxylic acid ester;R.sup.1 to R.sup.4 are each independently selected from H, C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, C.sub.1-4 -alkenyl, halogen and the group - X - Y;X is - O - or - S -; andY is C.sub.2-10 -alkenyl provided that,the substituents on rings A and B are different when Z.sup.1 and Z.sup.2 are the same or that Z.sup.1 and Z.sup.2 are different when the substituents on rings A and B are the same,which is suitable for the coloration of synthetic textile materials and processes for its preparation.Type: GrantFiled: October 29, 1985Date of Patent: July 14, 1987Assignee: Imperial Chemical Industries PlcInventors: Ronald W. Kenyon, Derek Thorp
-
Patent number: 4658043Abstract: Novel ethers of organic compounds containing chiral atoms of the formula ##STR1## wherein A is a hydrocarbonated chain of 1 to 10 groups, the said chain containing one or more heteroatoms, one or more unsaturations, the assembly of the groups constituting the chain may represent a mono- or polycyclic system, including a system of the spiro or endo type, the chain A can contain one or more chiral atoms or the lactone moiety can present a chirality due to the dissymetric spatial configuration of the whole of the molecule and Z is selected from the group consisting of primary, secondary or tertiary alcohol moiety containing at least an asymetric carbon atom, a phenol moiety substituted comprising at least one asymetric carbon atom and a substituted alcohol or phenol moiety with a chirality due to the dissymetric spatial configuration of the whole of the molecule, with the proviso Z is not (R) or (S) .alpha.Type: GrantFiled: June 17, 1985Date of Patent: April 14, 1987Assignee: Roussel UclafInventors: Jacques Martel, Jean Tessier, Andre Teche
-
Patent number: 4650882Abstract: A novel hetero-polycyclic compound of the following formula, a method for its preparation and its use in the coloration of textile materials: ##STR1## wherein, Z.sup.1 & Z.sup.2 are each independently --O--, --S-- or --NR.sup.5 -- in which R.sup.5 is H or an optionally-substituted hydrocarbon group or an acyl group;X.sup.1 & X.sup.2 are selected from H, halogen, cyano, C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, aryl, carbamoyl, sulphamoyl, carboxylic acid or carboxylic acid ester;R.sup.1 to R.sup.4 are each independently selected from H, C.sub.1-4 -alkyl, C.sub.1-4 -alkoxy, C.sub.1-4 -alkenyl, halogen and the group --X--Y;X is --O-- or --S--; andY is a group of the formula: ##STR2## wherein: V & W are each independently H or optionally substituted alkyl;p is an integer from 1 to 3;q is 0 or 1;p+q is at least 2; andZ is OR.sup.6 or NR.sup.6 R.sup.7 when q=1;or Z is OR.sup.8 or SR.sup.8 when q=0;wherein:R.sup.Type: GrantFiled: November 23, 1984Date of Patent: March 17, 1987Assignee: Imperial Chemical Industries PLCInventors: Ronald W. Kenyon, Derek Thorp
-
Patent number: 4644072Abstract: There is provided a novel and efficient stereoselective total synthesis of epipodophyllotoxin and related epipodophyllotoxin compounds of the general formula ##STR1## wherein R.sup.1 and R.sup.2 each are independently hydrogen or (lower)alkoxy, or R.sup.1 and R.sup.2, taken together, is methylenedioxy; R.sup.4 and R.sup.6 each are independently hydrogen or (lower)alkoxy; and R.sup.5 is hydrogen or a phenol-protecting group; or an acid addition salt thereof. The present invention also provides novel intermediates and processes for the preparation of said intermediates, which are then converted into known antineoplastic agents.Type: GrantFiled: April 12, 1985Date of Patent: February 17, 1987Assignee: Bristol-Myers CompanyInventors: Dolatrai M. Vyas, Paul M. Skonezny
-
Patent number: 4613637Abstract: A copolymer formed from an isoimide oligomer and another compound, such as an aryl sulfone, each of which has reactive functional terminal groups, such as ethylenic or acetylenic groups. The isoimide oligomer is soluble in the other compound, unreactive with the compound below a certain temperature and forms a liquid blend therewith. Upon heating the liquid blend above that certain temperature, the terminal groups on the isoimide oligomer and the other compound react with each other to form a copolymer. The liquid blends may be used to form encapsulants, coatings, films, and resin matrices for composites to provide resins with excellent high temperature properties.Type: GrantFiled: December 27, 1983Date of Patent: September 23, 1986Assignee: Hughes Aircraft CompanyInventors: Abraham L. Landis, Arthur B. Naselow
-
Patent number: 4540785Abstract: Hydroquinones of the formula ##STR1## wherein X is the residue of a 5- or 6-membered ring, R.sub.1 is hydrogen, alkyl or aryl, R.sub.1,R.sub.3, R.sub.4 and R.sub.5 are hydrogen or alkyl and R.sub.6 is hydrogen or a group of the formula ##STR2## wherein X and R.sub.1 are as defined above, are of use as protected developing agents in photographic silver halide material.Type: GrantFiled: November 8, 1983Date of Patent: September 10, 1985Assignee: Ciba-Geigy AGInventor: Norman A. Smith
-
Patent number: 4503240Abstract: Process for the preparation of 8,12-epoxy-13,14,15,16-tetranorlabdane by way of converting farnesyl bromide to farnesyl cyanide, followed by the saponification of the farnesyl cyanide to homofarnesic acid which is then cyclized to norambreinolide in the presence of titanium tetrachloride, converting the norambreinolide with LiAlH.sub.4 to 8-hydroxy-13,14,15,16-tetranorlabdane-12-ol, and cyclization of the diol in the presence of POCl.sub.3 to 8,12-epoxy-13,14,15,16-tetranorlabdane. The resulting product exhibits an amber scent, used in perfumery.Type: GrantFiled: July 28, 1983Date of Patent: March 5, 1985Assignee: Consortium F/u/ r Elektrochemische Industrie GmbHInventors: Gerhard Staiger, Antonio Macri
-
Patent number: 4496711Abstract: Processes for forming a class of relatively low molecular-weight oligomers containing at least one isoimide group and terminal groups capable of undergoing an addition polymerization reaction are provided. These oligomers are characterized by excellent solubility in common solvents and a melting temperature considerably lower than their cure temperature, thus enabling the oligomers to be formed into cured polymers more slowly and at lower temperatures, all without the evolution of deleterious gases. The process for forming these oligomers includes the formation of a polyamic acid and dehydration thereof under specified conditions to effect cyclization of the polyamic acid to form the isoimide-containing oligomer, without the formation of undesired side-reaction products.Type: GrantFiled: September 26, 1983Date of Patent: January 29, 1985Assignee: Hughes Aircraft CompanyInventor: Abraham L. Landis
-
Patent number: 4495342Abstract: A class of relatively low molecular-weight oligomers containing at least one isoimide group and terminal groups capable of undergoing an addition polymerization reaction are provided. These oligomers are characterized by excellent solubility in common solvents and a melting temperature considerably lower than their cure temperature, thus enabling the oligomers to be formed into cured polymers more slowly and at lower temperatures, all without the evolution of deleterious gases. The oligomers of the present invention may be formed by reacting an aromatic dianhydride with an aromatic diamine, followed by reaction with a monoanhydride. The resulting product is dehydrated to form the isoimide-containing oligomer.Type: GrantFiled: September 26, 1983Date of Patent: January 22, 1985Assignee: Hughes Aircraft CompanyInventor: Abraham L. Landis
-
Patent number: 4486445Abstract: A natural lignan of the 1-aryl-2-napthoic acid type and related compounds are disclosed. The compounds correspond to the formula ##STR1## and exhibit both insecticidal and antiviral activity.Type: GrantFiled: January 12, 1983Date of Patent: December 4, 1984Assignee: E. I. Du Pont de Nemours and CompanyInventors: Narayan G. Patel, Chia-Lin J. Wang
-
Patent number: 4485231Abstract: A class of relatively low molecular-weight oligomers containing at least one isoimide group and terminal groups capable of undergoing an addition polymerization reaction are provided. These oligomers are characterized by excellent solubility in common solvents and a melting temperature considerably lower than their cure temperature, thus enabling the oligomers to be formed into cured polymers more slowly and at lower temperatures, all without the evolution of deleterious gases. The oligomers of the present invention may be formed by reacting an aromatic dianhydride with an aromatic diamine, followed by reaction with a functional mono-amine. The resulting product is then dehydrated to form the isoimide-containing oligomer.Type: GrantFiled: September 26, 1983Date of Patent: November 27, 1984Assignee: Hughes Aircraft CompanyInventor: Abraham L. Landis
-
Patent number: 4438273Abstract: A class of relatively low molecular-weight oligomers containing at least one isoimide group and terminal groups capable of undergoing an addition polymerization reaction. The oligomers of the present invention are characterized by excellent solubility in common solvents and a melting temperature considerably lower than their cure temperature, thus enabling the oligomers to be formed into cured polymers more slowly and at lower temperatures, all without the evolution of deletrious gases.Type: GrantFiled: July 24, 1981Date of Patent: March 20, 1984Assignee: Hughes Aircraft CompanyInventor: Abraham L. Landis
-
Patent number: 4417059Abstract: This invention relates to 3,7-bis(disubstituted aminophenyl- or indolyl)-3,7-bis(diphenylamino)pyromellitides, 3,5-bis(disubstituted aminophenyl- or indolyl)-3,5-bis(diphenylamino)pyromellitides and mixtures thereof useful as color formers, particularly in carbonless duplicating and thermal marking systems, which are prepared by the interaction of 2,5-bis(disubstituted aminophenyl- or indolyl)carbonyl-1,4-benzenedicarboxylic acids or 2,4-bis(disubstituted aminophenyl- or indolyl)carbonyl-1,5-benzenedicarboxylic acids and mixtures thereof with diphenylamines.Type: GrantFiled: August 19, 1981Date of Patent: November 22, 1983Assignee: Sterling Drug Inc.Inventors: Paul J. Schmidt, William M. Hung
-
Patent number: 4410710Abstract: Naturally occurring iridoids provide the starting material for a unique synthesis sequence to produce prostaglandin intermediates. The iridoid lactone is hydrogenated, converted to an acetal, and rings opened to introduce the carbonyl octenyl side chain in six steps. The intermediate can be converted to prostaglandin as previously demonstrated.Type: GrantFiled: September 25, 1981Date of Patent: October 18, 1983Assignee: Research Foundation of the City University of New YorkInventors: William F. Berkowitz, Satish C. Choudhry, Joseph A. Hrabie
-
Patent number: 4343493Abstract: This invention relates to 3,7-bis(disubstituted aminophenyl- or indolyl)-3,7-bis(diphenylamino)pyromellitides, 3,5-bis(disubstituted aminophenyl- or indolyl)-3,5-bis(diphenylamino)pyromellitides and mixtures thereof useful as color formers, particularly in carbonless duplicating and thermal marking systems, which are prepared by the interaction of 2,5-bis(disubstituted aminophenyl- or indolyl)carbonyl-1,4-benzenedicarboxylic acids or 2,4-bis(disubstituted aminophenyl- or indolyl)carbonyl-1,5-benzenedicarboxylic acids and mixtures thereof with diphenylamines.Type: GrantFiled: August 29, 1980Date of Patent: August 10, 1982Assignee: Sterling Drug Inc.Inventors: Paul J. Schmidt, William M. Hung